| Print
Oramed Pharmaceuticals (ORMP)
Common SharesNot yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Address
1185 Avenue of the Americas
Suite 228
New York
NY
USA
10036
Telephone
+972 25660001
Forecast key dates
| Name | Key Date |
|---|---|
| Oramed Pharmaceuticals Inc Annual General Meeting for 2025 | 2026-08-19T10:00:00 |
| Oramed Pharmaceuticals Inc Second Quarter Earnings Results for 2026 | 2026-08-14T00:00:00 |
| Oramed Pharmaceuticals Inc First Quarter Earnings Results for 2026 | 2026-05-15T00:00:00 |
| Oramed Pharmaceuticals Inc Annual Report for 2025 | 2026-03-27T00:00:00 |
| Oramed Pharmaceuticals Inc Third Quarter Earnings Results for 2025 | 2025-11-07T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Oramed Pharmaceuticals Inc Annual General Meeting for 2024 | 2025-08-19T10:00:00 |
| Oramed Pharmaceuticals Inc Second Quarter Earnings Results for 2025 | 2025-08-14T00:00:00 |
| Oramed Pharmaceuticals Inc First Quarter Earnings Results for 2025 | 2025-05-15T00:00:00 |
| Oramed Pharmaceuticals Inc Annual Report for 2024 | 2025-03-27T00:00:00 |
| Oramed Pharmaceuticals Inc Third Quarter Earnings Results for 2024 | 2024-11-07T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.